Refine
Is part of the Bibliography
- yes (156)
Year of publication
Document Type
- Journal article (127)
- Doctoral Thesis (28)
- Preprint (1)
Keywords
- heart failure (17)
- echocardiography (9)
- Herzinsuffizienz (8)
- cardiomyopathy (6)
- magnetic resonance imaging (6)
- mitochondria (6)
- acute heart failure (5)
- myocardial infarction (5)
- prognosis (5)
- akute Herzinsuffizienz (4)
- atrial fibrillation (4)
- cardiovascular genetics (4)
- ischemic stroke (4)
- mortality (4)
- Barth syndrome (3)
- Herzhypertrophie (3)
- Herzmuskelkrankheit (3)
- MRI (3)
- Magnetic resonance imaging (3)
- chronic heart failure (3)
- deep learning (3)
- desmin (3)
- hypertension (3)
- radial (3)
- reactive oxygen species (3)
- 7 T (2)
- 7T (2)
- Arrhythmie (2)
- Beschleunigungssensor (2)
- CRISPR/Cas9 (2)
- Chronotrope Inkompetenz (2)
- DSG2 (2)
- EUROASPIRE (2)
- Fabry disease (2)
- Fluoreszenz (2)
- GFAP (2)
- Guidelines (2)
- Heart failure (2)
- Herzfrequenz (2)
- Herzmuskelzelle (2)
- Herzschrittmacher (2)
- Induzierte pluripotente Stammzelle (2)
- Koronare Herzkrankheit (2)
- Mitochondrium (2)
- Natrium-Calcium-Austauscher (2)
- Pulswelle (2)
- Quality of life (2)
- SGLT2 inhibitors (2)
- TRP-Kanäle (2)
- TRPC4 (2)
- accelerometer-sensor (2)
- amyloidosis (2)
- anxiety (2)
- arrhythmia (2)
- arrhythmogenic cardiomyopathy (2)
- atherosclerosis (2)
- biomarkers (2)
- carbohydrates (2)
- cardiac (2)
- cardiac device (2)
- cardiac magnetic resonance (2)
- cardiac magnetic resonance imaging (2)
- cardiac metabolism (2)
- cardiogenetics (2)
- cardiolipin (2)
- cardiology (2)
- cardiovascular diseases (2)
- cardiovascular implantable electronic device (2)
- cardiovascular risk factors (2)
- chronic kidney disease (2)
- chronotropic incompetence (2)
- cognitive impairment (2)
- coronary heart disease (2)
- depression (2)
- desmosomes (2)
- diabetes mellitus (2)
- diffusion tensor imaging (2)
- dilated cardiomyopathy (2)
- ejection fraction (2)
- glial fibrillary acidic protein (2)
- heart (2)
- heart rate (2)
- inflammation (2)
- internal medicine (2)
- left ventricular ejection fraction (2)
- mapping (2)
- morbidity (2)
- mouse (2)
- myocardial work (2)
- neural networks (2)
- norepinephrine transporter (2)
- positron emission tomography (2)
- quality (2)
- quality of life (2)
- regulatory T cells (2)
- respiratory chain (2)
- restrictive cardiomyopathy (2)
- secondary prevention (2)
- segmentation (2)
- theranostics (2)
- thorax (2)
- translational research (2)
- troponin (2)
- whole exome sequencing (2)
- 3D echocardiography (1)
- 3D printing (1)
- 3 T (1)
- 4D flow MRI (1)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- ACC/AHA classification (1)
- ACM (1)
- AHF (1)
- AHF-Register Würzburg (1)
- AI (1)
- ARVC (1)
- ASE formula (1)
- Acylcarnitin (1)
- Addison's disease (1)
- Alzheimer's disease (1)
- Angiotensin II (1)
- Aorta (1)
- Aortenklappe (1)
- Arrhythmogene Kardiomyopathie (1)
- Arrhythmogenic cardiomyopathy (1)
- Arterielle Gefäßsteifigkeit (1)
- Arteriosklerose (1)
- Asthma (1)
- Atherosclerosis (1)
- B (1)
- B-MYB (1)
- B0 (1)
- BDNF (1)
- Barth Syndrome (1)
- Bildgebendes Verfahren (1)
- Biobank (1)
- Bioluminescence (1)
- Blood pressure (1)
- Brain atrophy (1)
- Breathing (1)
- Brownian ratchet (1)
- Bypass (1)
- CD4+ T-cells (1)
- CMR (1)
- COVID-19 (1)
- CRISPR-Cas Systems (1)
- CRISPR/Cas-Methode (1)
- CXCR4 (1)
- Calcium (1)
- Calciumkanal (1)
- Calciumtransport (1)
- Calpain (1)
- Cardiac (1)
- Cardiac Efficiency (1)
- Cardiac MRI (1)
- Cardiac ventricles (1)
- CardioMEMS™ HF system (1)
- CardioMEMS™ HF-System (1)
- Cardiovascular disease (1)
- Cardiovascular diseases (1)
- Cardiovascular magnetic-resonance (1)
- Carotis Intima Media Dicke (1)
- Cavβ subunit (1)
- Cerebral-ischemia (1)
- Chronic heart failure (1)
- Chronic heart-failure (1)
- Chronic kidney disease (1)
- Chronic obstrusive pulmonary disease (1)
- Chronische Herzinsuffizienz (1)
- Chronische Nierenerkrankung (1)
- Clinical decision support system (1)
- Clinically silent stroke (1)
- Cognitive decline (1)
- Cognitive impairment (1)
- Collaboration (1)
- Coronary artery disease (1)
- Coronary heart disease (1)
- Cotransporter 2 inhibition (1)
- Cranial sutures (1)
- DSC2 (1)
- DTI (1)
- Data acquisition (1)
- Deep learning (1)
- Diagnostic medicine (1)
- Diffusion tensor imaging (1)
- Diffusionsgewichtete Magnetresonanztomografie (1)
- Dilated Cardiomyopathy with Ataxia (1)
- Diseases (1)
- Dokumentationsqualität (1)
- Double-blind (1)
- E/e’ (1)
- ERK1/2 (1)
- Echocardiography (1)
- Echokardiographie (1)
- Echtes WRF (1)
- Eigenvectors (1)
- Embryos (1)
- Endorganschaden (1)
- English version (1)
- Enhancer elements (1)
- Entscheidungsunterstützungssystem (1)
- Enzyme replacement therapy (1)
- Excitation-Transcription-Coupling (1)
- Extracellular volume (1)
- FKBP52 (1)
- Fabry Disease (FD) (1)
- Fabry-associated pain (1)
- Friedreich’s ataxia (1)
- GDNF (1)
- Gb3 and lyso-Gb3 biomarkers (1)
- Gefäßalter (1)
- Genanalyse (1)
- Germany (1)
- Glatiramer acetate (1)
- Glial fibrillary acidic protein (1)
- HFpEF (1)
- HMDP hydroxymethylene diphosphonate (1)
- Head-injury (1)
- Heart (1)
- Heart Failure (1)
- Hemodynamic depression (1)
- Herzdekompensation (1)
- Herzthoraxchirurgie (1)
- Hesse (1)
- HiGHmed (1)
- Hindbrain (1)
- Hospitalization (1)
- Hypertension (1)
- Hypertrophic cardiomyopathy (1)
- Hämodialyse (1)
- IP3 signaling (1)
- IP3-Signaling (1)
- Immunkardiologie (1)
- Immunocardiology (1)
- Immunologie (1)
- Immunophilin (1)
- Induced Pluripotent Stem Cells (1)
- Inflammation (1)
- Inositoltrisphosphat (1)
- Integrated Palliative care outcome scale (1)
- Intensivtransport (1)
- Interhospitaltransfer (1)
- Intravascular coagulation (1)
- Journal of Nuclear Cardiology (1)
- KHK (1)
- KWIC (1)
- Kandidatengen (1)
- Kardiologie (1)
- Kernspintomografie (1)
- Kognitive Defizite (1)
- Kreatinin (1)
- Künstliche Intelligenz (1)
- L-type calcium channels (1)
- LMNA (1)
- LTCC-independent function of Cavβ (1)
- LV Function (1)
- LV dilatation (1)
- LVNC (1)
- Langzeitbeatmung (1)
- Langzeitlagerung (1)
- Lebensqualität (1)
- Long COVID (1)
- MOLLI (1)
- Management (1)
- Manifestation (1)
- Massive parallele Sequenzierung (1)
- Measurement (1)
- Medicine (1)
- Mellitus (1)
- Memory dysfunction (1)
- Mice (1)
- MitoQ (1)
- Mitochondrialer Uniporter (MCU) (1)
- Mitochondrialer Uniporter Knock out (MCU-KO) (1)
- Mitofusin2 (1)
- MitraClip (1)
- Model (1)
- Molecular-weight heparin (1)
- Mortality (1)
- Mortalität (1)
- Mouse models (1)
- Mutation (1)
- Myb-MuvB (1)
- Myocardial Work (1)
- Myocardial fibrosis (1)
- Myocardial infarction (1)
- Myocardial-perfusion SPECT (1)
- Myokardinfarkt (1)
- NEC (1)
- NET (1)
- NOAC (1)
- NSG animals (1)
- NT-proBNP (1)
- NT‐proBNP (1)
- Na+/K+-ATPase (1)
- Natrium-Kalium-Pumpe (1)
- Neurodegeneration (1)
- Neurons (1)
- NfL (1)
- Niereninsuffizienz (1)
- OXPHOS (1)
- Oxygen (1)
- PKA (1)
- PKP2 (1)
- PWV (1)
- Pain questionnaire (1)
- Palliativmedizin (1)
- Placebo-controlled trial (1)
- Plasma (1)
- Prevalence (1)
- Prognostic impact (1)
- Protons (1)
- Pseudo-WRF (1)
- Pulmonary imaging (1)
- RKIP (1)
- ROS (1)
- Raman micro-spectroscopy (1)
- Rats (1)
- Risiko (1)
- Risk-factors (1)
- Röntgen-Thorax (1)
- S-glutathionylation (1)
- SAR safety (1)
- SASHA (1)
- SF-36 (1)
- SPECT (1)
- SR/Mitochondriales Feedback (1)
- ST-elevation myocardial infarction (1)
- STAAB Cohort Study (1)
- STEMI (1)
- Sars-CoV-2 (1)
- Scar (1)
- Score (1)
- Segmentation (1)
- Selbstwirksamkeit (1)
- Self-efficacy (1)
- Sengers syndrome (1)
- Septal bulge (1)
- Serum (1)
- ShMOLLI (1)
- Shimming (1)
- Skull (1)
- Somites (1)
- Spironolacton (1)
- Stabilität (1)
- Sterblichkeit (1)
- Stiffness (1)
- Stoffwechsel (1)
- Stroke (1)
- Survival (1)
- Swine (1)
- Systole (1)
- T cells (1)
- T-shaped π–π stacking (1)
- T1 mapping (1)
- T1rho (1)
- T1ρ (1)
- TMEM43 (1)
- TRPC (1)
- TRPC-Ionenkanäle (1)
- TT\(_{1rho}\) mapping (1)
- T\(_{1P}\) dispersion (1)
- T\(_{1P}\) mapping (1)
- Tabakkonsum (1)
- Tandem-Peptid (1)
- Task force (1)
- Teichholz formula (1)
- Thrombus formation (1)
- Time measurement (1)
- Tobacco smoking (1)
- Tractography (1)
- Ultrahigh field (1)
- VARS2 (1)
- Valvular heart-desease (1)
- Vaskuläre Funktion (1)
- Ventricular-arrhythmias (1)
- Verdachtsgenerierung (1)
- Versorgungsforschung (1)
- Versorgungsprogramm (1)
- WSS (1)
- Wasted Work (1)
- Weaning (1)
- Weight (1)
- YAP (1)
- Zebrafish (1)
- acid sphingomyelinase (1)
- acute decompensated heart failure (1)
- adaptive immune response (1)
- adverse effects (1)
- age-related hearing loss (1)
- akute Niereninsuffizienz (1)
- alveolar epithelium in vitro model, claudin-1, claudin-3, claudin-4, claudin-5 (1)
- amyloid cardiomyopathy (1)
- anaemia (1)
- aneurysm (1)
- antenna (1)
- anti-myocardial (1)
- antibody/autoantibody (1)
- anticoagulation (1)
- antidepressants (1)
- antithrombotic therapy (1)
- anxious depression (1)
- aortic arch (1)
- aortic valve stenosis (1)
- areas (1)
- arterial stiffening (1)
- augmentation (1)
- autoantibody (1)
- basic (1)
- blood coagulation factor XIII (1)
- blood plasma (1)
- blood pressure (1)
- blood pressure monitoring (1)
- blood–brain barrier (1)
- blood–labyrinth barrier (1)
- body (1)
- bolus-based perfusion measurement (1)
- bridging (1)
- cadherins (1)
- calcification (1)
- calcium cycling (1)
- calcium imaging (1)
- calcium signaling (1)
- cancer (1)
- cancer treatment (1)
- candidate genes (1)
- cardiac MRI (1)
- cardiac arrest (1)
- cardiac function (1)
- cardiac imaging (1)
- cardiac training group (1)
- cardioprotective potential (1)
- cardiovascular MR methods (1)
- cardiovascular MRI (1)
- cardiovascular drugs (1)
- cardiovascular magnetic resonance (1)
- cardiovascular magnetic resonance (CMR) (1)
- care tempis (1)
- carotid artery disease (1)
- case report (1)
- catecholamines (1)
- cell biology (1)
- cell staining (1)
- cerebral microbleeds (1)
- channel transport (1)
- chest-x-ray (1)
- cholesterol (1)
- clinical data warehouse (1)
- clinical routine data (1)
- clinical study (1)
- clinical systems (1)
- cluster analysis (1)
- cognitive decline (1)
- coherent anti-Stokes Raman scattering (CARS) microscopy (1)
- comorbidity (1)
- comparability (1)
- computational fluid dynamics (1)
- computed tomography (1)
- conformational auto-epitope (1)
- congestion (1)
- contractility (1)
- coronary arteries (1)
- coronary artery bypass grafting (1)
- coronary artery disease (1)
- correction (1)
- cross-cultural comparison (1)
- cyclic peptides/cyclopeptides (1)
- cyclopeptide therapy (1)
- cytokines (1)
- cytotoxic T cells (1)
- data acquisition (1)
- death rates (1)
- deformation (1)
- dementia (1)
- density (1)
- depressive disorder (1)
- design (1)
- desmin-related myopathy (1)
- desminopathy (1)
- desmocollin-2 (1)
- desmoglein-2 (1)
- desmosomal mutations (1)
- diagnostic medicine (1)
- diastolic dysfunction (1)
- diastolic function (1)
- diet (1)
- digital Health (1)
- dilated cardiomyopathy with ataxia (1)
- dilated cardiomyopathy with ataxia (DCMA) (1)
- disease score (1)
- disease severity (1)
- documentation quality (1)
- drug interaction (1)
- drug intoxication (1)
- drug toxicity (1)
- eGFR (1)
- echo planar imaging (1)
- editorial (1)
- elamipretide (1)
- electromagnetics (1)
- electronic data capture (1)
- electronic health records (1)
- electrophysiology (1)
- element (1)
- endovascular treatment (1)
- enhancer (1)
- entropy production (1)
- evidence-based practice (1)
- expert opinion (1)
- fatty acids (1)
- female (1)
- filamin-C (1)
- flow dynamics (1)
- food consumption (1)
- free energy (1)
- free‐breathing (1)
- functional magnetic resonance imaging (1)
- functional mitral regurgitation (1)
- gene panel (1)
- genetics (1)
- giant intracranial aneurysm (1)
- glial damage (1)
- glomerular filtration rate (1)
- glucocorticoid replacement therapy (1)
- guideline-directed medical therapy (1)
- guidelines (1)
- haemodialysis (1)
- haemodynamic monitoring (1)
- healing and remodelling processes (1)
- health care (1)
- health policy (1)
- health-related quality of life (1)
- health‐related quality of life (1)
- heart disease (1)
- heart failure training group (1)
- heart failure with mid-range ejection fraction (1)
- heart failure with reduced ejection fraction (1)
- heart rate variability (1)
- heart structure (1)
- heart valve bypass (1)
- hemodialysis (1)
- heterozygote (1)
- high-field MRI (1)
- hospitals (1)
- human behaviour (1)
- human induced pluripotent stem cells (hiPSC) (1)
- humans (1)
- iPSC-CMs (1)
- iPSC-cardiomyocytes (1)
- iPSC-derived CMs (iPSC-CMs) (1)
- image processing (1)
- images (1)
- imaging techniques (1)
- immune cells (1)
- immunohistochemistry (1)
- immunosenescence (1)
- implementation (1)
- in vitro model system of inherited cardiomyopathies (1)
- in vivo imaging (1)
- in-vivo (1)
- induced pluripotent stem cells (iPSCs) (1)
- infarction size (1)
- infection (1)
- inferior vena cava (1)
- inflammaging (1)
- inherited cardiomyopathies (1)
- insulin tolerance test (1)
- integrated stress response (1)
- intensity of attention (1)
- intensive care transport (1)
- interhospital transfer (1)
- intermediate filaments (1)
- interparticle interaction (1)
- ischemic-stroke (1)
- junctions (1)
- kidney (1)
- kidney function (1)
- lactic acidosis (1)
- large animal models (1)
- left ventricular geometric abnormality (1)
- left ventricular geometry (1)
- left ventricular hypertrophy (1)
- left ventricular mass (1)
- left ventricular mass index (1)
- left ventricular performance (1)
- left ventricular remodeling (1)
- left ventricular thrombusv (1)
- left-ventricular function (1)
- lifestyle (1)
- linear regression analysis (1)
- long-term ventilation (1)
- low molecular heparin (1)
- lung (1)
- lymphocyte differentiation (1)
- lymphocytes (1)
- lysosomal storage disorders (1)
- m exercise training (1)
- mHealth (1)
- magnetic resoncance (1)
- major depression (1)
- management (1)
- matched filters (1)
- maturation strategies (1)
- mavacamten (1)
- meat (1)
- mechanisms (1)
- medical data integration center (1)
- medical informatics initiative (1)
- medical rehabilitation (1)
- meningioma (1)
- metabolism (1)
- metastasis (1)
- mice (1)
- middle aged (1)
- mild (1)
- mitochondria function and morphology (1)
- mitochondrial FAO (1)
- mitochondrial cardiomyopathy (1)
- mitochondrialer Ryanodin-Rezeptor (mRyR1) (1)
- mitotic genes (1)
- molecular biology (1)
- molecular imaging (1)
- molecular medicine (1)
- multivariate data analysis (1)
- music performance anxiety (1)
- mutations (1)
- myocardial aging (1)
- myocardial blood flow (1)
- myocardial perfusion reserve (1)
- myocardial work efficiency (1)
- myofilament proteins (1)
- myokardiale Arbeit (1)
- myosin (1)
- natriuretic peptide (1)
- nephrology (1)
- neuroblastoma (1)
- neurodevelopmental disorders / genetics (1)
- neuroendocrine neoplasms (NEN) (1)
- neuroendocrine tumors (NET) (1)
- neurofilament light chain (1)
- neuroinflammation (1)
- neurological (1)
- neurology (1)
- neuroscience (1)
- neurotrophins (1)
- next generation sequencing (1)
- nicotinamide nucleotide transhydrogenase (1)
- nnU-net (1)
- non-equilibrium thermodynamics (1)
- normal values (1)
- ollimator (1)
- omecamtiv mecarbil (1)
- on-site examination (1)
- oncology (1)
- openEHR (1)
- optimization (1)
- oral anticoagulants (1)
- organoid (1)
- outcomes (1)
- oxidative stress (1)
- pCa (1)
- percutaneous mitral valve repair (1)
- pharmacotherapy (1)
- phosphorylation (1)
- pig (1)
- pilot project (1)
- plaque characteristics (1)
- plasma proteins (1)
- population-based (1)
- post-reconstruction filtering (1)
- postmenopausal women (1)
- postoperative bleeding (1)
- poultry (1)
- power grids (1)
- progressive muscle relaxation (1)
- prostate cancer (1)
- prostate-specific membrane antigen (PSMA) (1)
- public health (1)
- pulmonary artery pressure (1)
- quantitative MRI (1)
- randomized controlled trial (1)
- real-world (1)
- recovery (1)
- reference data (1)
- rehabilitation (1)
- relaxometry (1)
- religion (1)
- remote monitoring (1)
- renal (1)
- renal function (1)
- research (1)
- research infrastructure (1)
- right heart impairment (1)
- right ventricular dysfunction (1)
- risk prediction scores (1)
- rumenic acid (1)
- sacubitril-valsartan (1)
- scanner (1)
- secondary data usage (1)
- self‐gated (1)
- semantic interoperability (1)
- semantic segmentation (1)
- sensitivity analysis (1)
- sex differences (1)
- shimming (1)
- short Synacthen test (1)
- sigma-1 receptor-directed molecular imaging (1)
- signal filtering (1)
- signal to noise ratio (1)
- six-minute walk test (1)
- skeletal (1)
- skinned fiber (1)
- small animal (1)
- small animal SPECT (1)
- small-animal imaging (1)
- social support (1)
- sodium-glucose co-transporter-2 inhibitors (1)
- somatostatin receptor (SSTR) (1)
- speckle tracking (1)
- speech recognition (1)
- sphingolipids (1)
- spin lock (1)
- spin-lock (1)
- spiral ganglion neuron (1)
- spironolactone (1)
- sports and exercise medicine (1)
- state space (1)
- statins (1)
- statistical data (1)
- statistical mechanics (1)
- stem cells (1)
- stem-cell research (1)
- stenosis (1)
- stepped impedance resonators (1)
- stroke (1)
- structure–activity relationships (1)
- study-group ADSR (1)
- sudden cardiac death (1)
- surgical aneurysm treatment (1)
- swine (1)
- sympathetic nervous system (1)
- systems biology (1)
- tandem peptide (1)
- targeted gene panel (1)
- therapy (1)
- therapy response (1)
- thermodynamics (1)
- thromboembolism (1)
- thrombolysis (1)
- time (1)
- trait emotional intelligence (1)
- transceiver array (1)
- transcription (1)
- transfer learning (1)
- transformations (1)
- transient ischemic attack (1)
- translational (1)
- ultrahigh field (1)
- ultrahigh-field (1)
- ultrahigh-field MRI (1)
- ultrasound (1)
- under-dosing (1)
- undersampling (1)
- urology (1)
- usability (1)
- user-centered design (1)
- vena contracta area (1)
- virtual reality exposure therapy (1)
- warfarin interruption (1)
- wave interference (1)
- wave‐CAIPI (1)
- weaning (1)
- zebrafish (1)
- Überleben (1)
- α-Ketoglutarate dehydrogenase (1)
- β1-adrenoceptor/β1-adrenergic receptor (1)
- βAR (1)
Institute
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (156) (remove)
Sonstige beteiligte Institutionen
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (2)
- Center for Interdisciplinary Clinical Research, Würzburg University, Würzburg, Germany (1)
- Datenintegrationszentrum Würzburg (DIZ) (1)
- Department of Medicinal Chemistry, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Althanstraße 14, 1090 Vienna, Austria (1)
- Interdisziplinäre Biomaterial- und Datenbank Würzburg (ibdw) (1)
- Interdisziplinäre Zentrum für Klinische Forschung (IZKF) (1)
- Interdisziplinäres Amyloidosezentrum Nordbayern (1)
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) (1)
- Klinische Studienzentrale (Universitätsklinikum) (1)
We aimed to determine a detailed regional ventricular distribution pattern of the novel cardiac nerve PET radiotracer \(^{18}\)F-LMI1195 in healthy rabbits. Ex-vivo high resolution autoradiographic imaging was conducted to identify accurate ventricular distribution of \(^{18}\)F-LMI1195. In healthy rabbits, \(^{18}\)F-LMI1195 was administered followed by the reference perfusion marker \(^{201}\)Tl for a dual-radiotracer analysis. After 20 min of \(^{18}\)F-LMI1195 distribution time, the rabbits were euthanized, the hearts were extracted, frozen, and cut into 20-μm short axis slices. Subsequently, the short axis sections were exposed to a phosphor imaging plate to determine \(^{18}\)F-LMI1195 distribution (exposure for 3 h). After complete \(^{18}\)F decay, sections were re-exposed to determine 201Tl distribution (exposure for 7 days). For quantitative analysis, segmental regions of Interest (ROIs) were divided into four left ventricular (LV) and a right ventricular (RV) segment on mid-ventricular short axis sections. Subendocardial, mid-portion, and subepicardial ROIs were placed on the LV lateral wall. \(^{18}\)F-LMI1195 distribution was almost homogeneous throughout the LV wall without any significant differences in all four LV ROIs (anterior, posterior, septal and lateral wall, 99 ± 2, 94 ± 5, 94 ± 4 and 97 ± 3%LV, respectively, n.s.). Subepicardial \(^{201}\)Tl uptake was significantly lower compared to the subendocardial portion (subendocardial, mid-portion, and subepicardial activity: 90 ± 3, 96 ± 2 and *80 ± 5%LV, respectively, *p < 0.01 vs. mid-portion). This was in contradistinction to the transmural wall profile of \(^{18}\)F-LMI1195 (90 ± 4, 96 ± 5 and 84 ± 4%LV, n.s.). A slight but significant discrepant transmural radiotracer distribution pattern of \(^{201}\)Tl in comparison to \(^{18}\)F-LMI1195 may be a reflection of physiological sympathetic innervation and perfusion in rabbit hearts.
Mutations in mitochondrial aminoacyl-tRNA synthetases (mtARSs) have been reported in patients with mitochondriopathies: most commonly encephalopathy, but also cardiomyopathy. Through a GWAS, we showed possible associations between mitochondrial valyl-tRNA synthetase (VARS2) dysregulations and non-ischemic cardiomyopathy. We aimed to investigate the possible consequences of VARS2 depletion in zebrafish and cultured HEK293A cells. Transient VARS2 loss-of-function was induced in zebrafish embryos using Morpholinos. The enzymatic activity of VARS2 was measured in VARS2-depleted cells via northern blot. Heterozygous VARS2 knockout was established in HEK293A cells using CRISPR/Cas9 technology. BN-PAGE and SDS-PAGE were used to investigate electron transport chain (ETC) complexes, and the oxygen consumption rate and extracellular acidification rate were measured using a Seahorse XFe96 Analyzer. The activation of the integrated stress response (ISR) and possible disruptions in mitochondrial fatty acid oxidation (FAO) were explored using RT-qPCR and western blot. Zebrafish embryos with transient VARS2 loss-of-function showed features of heart failure as well as indications of CNS and skeletal muscle involvements. The enzymatic activity of VARS2 was significantly reduced in VARS2-depleted cells. Heterozygous VARS2-knockout cells showed a rearrangement of ETC complexes in favor of complexes III\(_2\), III\(_2\) + IV, and supercomplexes without significant respiratory chain deficiencies. These cells also showed the enhanced activation of the ISR, as indicated by increased eIF-2α phosphorylation and a significant increase in the transcript levels of ATF4, ATF5, and DDIT3 (CHOP), as well as disruptions in FAO. The activation of the ISR and disruptions in mitochondrial FAO may underlie the adaptive changes in VARS2-depleted cells.
Patients with genetic cardiomyopathy that involves myocardial hypertrophy often develop clinically relevant arrhythmias that increase the risk of sudden death. Consequently, guidelines for medical device therapy were established for hypertrophic cardiomyopathy, but not for conditions with only anecdotal evidence of arrhythmias, like Fabry cardiomyopathy. Patients with Fabry cardiomyopathy progressively develop myocardial fibrosis, and sudden cardiac death occurs regularly. Because 24-hour Holier electrocardiograms (ECGs) might not detect clinically important arrhythmias, we tested an implanted loop recorder for continuous heart rhythm surveillance and determined its impact on therapy. This prospective study included 16 patients (12 men) with advanced Fabry cardiomyopathy, relevant hypertrophy, and replacement fibrosis in "loco typico." No patients previously exhibited clinically relevant arrhythmias on Holier ECGs. Patients received an implantable loop recorder and were prospectively followed with telemedicine for a median of 1.2 years (range 0.3 to 2.0 years). The primary end point was a clinically meaningful event, which required a therapy change, captured with the loop recorder. Patients submitted data regularly (14 +/- 11 times per month). During follow-up, 21 events were detected (including 4 asystole, i.e., ECG pauses >= 3 seconds) and 7 bradycardia events; 5 episodes of intermittent atrial fibrillation (>3 minutes) and 5 episodes of ventricular tachycardia (3 sustained and 2 nonsustained). Subsequently, as defined in the primary end point, 15 events leaded to a change of therapy. These patients required therapy with a pacemaker or cardioverter defibrillator implantation and/or anticoagulation therapy for atrial fibrillation. In conclusion, clinically relevant arrhythmias that require further device and/or medical therapy are often missed with Holier ECGs in patients with advanced stage Fabry cardiomyopathy, but they can be detected by telemonitoring with an implantable loop recorder.
Usability of a mHealth solution using speech recognition for point-of-care diagnostic management
(2023)
The administrative burden for physicians in the hospital can affect the quality of patient care. The Service Center Medical Informatics (SMI) of the University Hospital Würzburg developed and implemented the smartphone-based mobile application (MA) ukw.mobile1 that uses speech recognition for the point-of-care ordering of radiological examinations. The aim of this study was to examine the usability of the MA workflow for the point-of-care ordering of radiological examinations. All physicians at the Department of Trauma and Plastic Surgery at the University Hospital Würzburg, Germany, were asked to participate in a survey including the short version of the User Experience Questionnaire (UEQ-S) and the Unified Theory of Acceptance and Use of Technology (UTAUT). For the analysis of the different domains of user experience (overall attractiveness, pragmatic quality and hedonic quality), we used a two-sided dependent sample t-test. For the determinants of the acceptance model, we employed regression analysis. Twenty-one of 30 physicians (mean age 34 ± 8 years, 62% male) completed the questionnaire. Compared to the conventional desktop application (DA) workflow, the new MA workflow showed superior overall attractiveness (mean difference 2.15 ± 1.33), pragmatic quality (mean difference 1.90 ± 1.16), and hedonic quality (mean difference 2.41 ± 1.62; all p < .001). The user acceptance measured by the UTAUT (mean 4.49 ± 0.41; min. 1, max. 5) was also high. Performance expectancy (beta = 0.57, p = .02) and effort expectancy (beta = 0.36, p = .04) were identified as predictors of acceptance, the full predictive model explained 65.4% of its variance. Point-of-care mHealth solutions using innovative technology such as speech-recognition seem to address the users’ needs and to offer higher usability in comparison to conventional technology. Implementation of user-centered mHealth innovations might therefore help to facilitate physicians’ daily work.
Aims
Chronic heart failure (CHF) can be caused by autoantibodies stimulating the heart via binding to first and/or second extracellular loops of cardiac β1-adrenoceptors. Allosteric receptor activation depends on conformational features of the autoantibody binding site. Elucidating these features will pave the way for the development of specific diagnostics and therapeutics. Our aim was (i) to fine-map the conformational epitope within the second extracellular loop of the human β\(_1\)-adrenoceptor (β1ECII) that is targeted by stimulating β\(_1\)-receptor (auto)antibodies and (ii) to generate competitive cyclopeptide inhibitors of allosteric receptor activation, which faithfully conserve the conformational auto-epitope.
Methods and results
Non-conserved amino acids within the β\(_1\)EC\(_{II}\) loop (compared with the amino acids constituting the ECII loop of the β\(_2\)-adrenoceptor) were one by one replaced with alanine; potential intra-loop disulfide bridges were probed by cysteine–serine exchanges. Effects on antibody binding and allosteric receptor activation were assessed (i) by (auto)antibody neutralization using cyclopeptides mimicking β1ECII ± the above replacements, and (ii) by (auto)antibody stimulation of human β\(_1\)-adrenoceptors bearing corresponding point mutations. With the use of stimulating β\(_1\)-receptor (auto)antibodies raised in mice, rats, or rabbits and isolated from exemplary dilated cardiomyopathy patients, our series of experiments unmasked two features of the β\(_1\)EC\(_{II}\) loop essential for (auto)antibody binding and allosteric receptor activation: (i) the NDPK\(^{211–214}\) motif and (ii) the intra-loop disulfide bond C\(^{209}\)↔C\(^{215}\). Of note, aberrant intra-loop disulfide bond C\(^{209}\)↔C\(^{216}\) almost fully disrupted the functional auto-epitope in cyclopeptides.
Conclusions
The conformational auto-epitope targeted by cardio-pathogenic β\(_1\)-receptor autoantibodies is faithfully conserved in cyclopeptide homologues of the β\(_1\)EC\(_{II}\) loop bearing the NDPK\(^{211–214}\) motif and the C\(^{209}\)↔C\(^{215}\) bridge while lacking cysteine C216. Such molecules provide promising tools for novel diagnostic and therapeutic approaches in β\(_1\)-autoantibodypositive CHF.
Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research
(2023)
A key step in translational cardiovascular research is the use of large animal models to better understand normal and abnormal physiology, to test drugs or interventions, or to perform studies which would be considered unethical in human subjects. Ultrahigh field magnetic resonance imaging (UHF-MRI) at 7 T field strength is becoming increasingly available for imaging of the heart and, when compared to clinically established field strengths, promises better image quality and image information content, more precise functional analysis, potentially new image contrasts, and as all in-vivo imaging techniques, a reduction of the number of animals per study because of the possibility to scan every animal repeatedly. We present here a solution to the dual use problem of whole-body UHF-MRI systems, which are typically installed in clinical environments, to both UHF-MRI in large animals and humans. Moreover, we provide evidence that in such a research infrastructure UHF-MRI, and ideally combined with a standard small-bore UHF-MRI system, can contribute to a variety of spatial scales in translational cardiovascular research: from cardiac organoids, Zebra fish and rodent hearts to large animal models such as pigs and humans. We present pilot data from serial CINE, late gadolinium enhancement, and susceptibility weighted UHF-MRI in a myocardial infarction model over eight weeks. In 14 pigs which were delivered from a breeding facility in a national SARS-CoV-2 hotspot, we found no infection in the incoming pigs. Human scanning using CINE and phase contrast flow measurements provided good image quality of the left and right ventricle. Agreement of functional analysis between CINE and phase contrast MRI was excellent. MRI in arrested hearts or excised vascular tissue for MRI-based histologic imaging, structural imaging of myofiber and vascular smooth muscle cell architecture using high-resolution diffusion tensor imaging, and UHF-MRI for monitoring free radicals as a surrogate for MRI of reactive oxygen species in studies of oxidative stress are demonstrated. We conclude that UHF-MRI has the potential to become an important precision imaging modality in translational cardiovascular research.
Background
Telemedicine improves the quality of acute stroke care in rural regions with limited access to specialized stroke care. We report the first 2 years' experience of implementing a comprehensive telemedical stroke network comprising all levels of stroke care in a defined region.
Methods
The TRANSIT-Stroke network covers a mainly rural region in north-western Bavaria (Germany). All hospitals providing acute stroke care in this region participate in TRANSIT-Stroke, including four hospitals with a supra-regional certified stroke unit (SU) care (level III), three of those providing teleconsultation to two hospitals with a regional certified SU (level II) and five hospitals without specialized SU care (level I). For a two-year-period (01/2015 to 12/2016), data of eight of these hospitals were available; 13 evidence-based quality indicators (QIs) related to processes during hospitalisation were evaluated quarterly and compared according to predefined target values between level-I- and level-II/III-hospitals.
Results
Overall, 7881 patients were included (mean age 74.6 years +/- 12.8; 48.4% female). In level-II/III-hospitals adherence of all QIs to predefined targets was high ab initio. In level-I-hospitals, three patterns of QI-development were observed: a) high adherence ab initio (31%), mainly in secondary stroke prevention; b) improvement over time (44%), predominantly related to stroke specific diagnosis and in-hospital organization; c) no clear time trends (25%). Overall, 10 out of 13 QIs reached predefined target values of quality of care at the end of the observation period.
Conclusion
The implementation of the comprehensive TRANSIT-Stroke network resulted in an improvement of quality of care in level-I-hospitals.
Multiple activities are ascribed to the cytokine tumor necrosis factor (TNF) in health and disease. In particular, TNF was shown to affect carcinogenesis in multiple ways. This cytokine acts via the activation of two cell surface receptors, TNFR1, which is associated with inflammation, and TNFR2, which was shown to cause anti-inflammatory signaling. We assessed the effects of TNF and its two receptors on the progression of pancreatic cancer by in vivo bioluminescence imaging in a syngeneic orthotopic tumor mouse model with Panc02 cells. Mice deficient for TNFR1 were unable to spontaneously reject Panc02 tumors and furthermore displayed enhanced tumor progression. In contrast, a fraction of wild type (37.5%), TNF deficient (12.5%), and TNFR2 deficient mice (22.2%) were able to fully reject the tumor within two weeks. Pancreatic tumors in TNFR1 deficient mice displayed increased vascular density, enhanced infiltration of CD4+ T cells and CD4+ forkhead box P3 (FoxP3)+ regulatory T cells (Treg) but reduced numbers of CD8+ T cells. These alterations were further accompanied by transcriptional upregulation of IL4. Thus, TNF and TNFR1 are required in pancreatic ductal carcinoma to ensure optimal CD8+ T cell-mediated immunosurveillance and tumor rejection. Exogenous systemic administration of human TNF, however, which only interacts with murine TNFR1, accelerated tumor progression. This suggests that TNFR1 has basically the capability in the Panc02 model to trigger pro-and anti-tumoral effects but the spatiotemporal availability of TNF seems to determine finally the overall outcome.